<DOC>
	<DOC>NCT00444548</DOC>
	<brief_summary>[S,S]-Reboxetine will be used to evaluate pharmacodynamic changes in urethral function in healthy volunteers using a novel methodology</brief_summary>
	<brief_title>Evaluation of A Novel Methodology in the Assessment of Urethral Function Using [S,S]-Reboxetine in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Healthy female subjects, aged 1865 years. Subjects must be nonpregnant and nonlactating, and be either post menopausal (greater than 1 year without menses), surgically sterilized, or using another acceptable form of contraception. Subjects of child bearing potential must have confirmed negative pregnancy tests at screening and prior to commencing all study periods. Evidence or history of clinically significant disease (including drug allergies, but excluding untreated, asymptomatic,seasonal allergies at time of dosing). Subjects with any clinically significant abnormality following review of laboratory data, urinalysis and physical examination.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Equipment</keyword>
	<keyword>Supplies</keyword>
</DOC>